Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A squamous cell carcinoma that arises from the nasal cavity mucosa. Signs and symptoms include nasal fullness and obstruction, pain, epistaxis, and the presence of a nasal mass.
3 clinical trials registered, 2 recruiting. Interventions under study include procedural interventions, drug therapy, and biologic therapy. Pipeline includes 2 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
2 publications have been identified in PubMed for nasal cavity squamous cell carcinoma. Research spans Clinical Trial Publication (50%) and Epidemiology / Natural History (50%).
Zeng Q (2025). [PMID: 40707549](https://pubmed.ncbi.nlm.nih.gov/40707549/). *Scientific reports*. [Epidemiology / Natural History]
Nishiya Y (2024). [PMID: 39427373](https://pubmed.ncbi.nlm.nih.gov/39427373/). *Auris, nasus, larynx*. [Clinical Trial Publication]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 2:54 PM UTC
AI-curated news mentioning nasal cavity squamous cell carcinoma
Updated May 10, 2026
A recent study highlights adolescent-onset primary small cell neuroendocrine carcinoma of the nasal cavity as a rare and aggressive cancer, yet with a favorable outcome. This research contributes to the understanding of this uncommon disease and its clinical implications.